About Wallcur

In October 2023, 3B Scientific acquired Wallcur LLC, a prominent provider of healthcare simulation products. This acquisition broadens 3B Scientific's product offering and further demonstrates our ongoing commitment to advancing medical training.

With a mission to enhance medical training and improve patient outcomes, Wallcur has been a trusted name in the industry for over 40 years. Wallcur’s journey began with a simple yet powerful idea: to bridge the gap between classroom learning and real-world patient care. Today, Wallcur is known to offer a wide range of high-quality healthcare simulation products and solutions tailored to meet the diverse needs of educators, healthcare professionals, and institutions.

The teams at Wallcur comprise of dedicated professionals who are deeply passionate about healthcare education. From product development to customer support, –everyone at Wallcur is driven by a shared vision: to empower the healthcare community with the tools and knowledge necessary to save lives.

Solutions to Improve Medical Simulation

Click Here to See Full Range of Simulated Medication.

Wallcur is offering a broad range of solutions to improve medical simulation. For example, the Practi®-brand guarantees the highest quality, true-to-life realistic design, creating a safe and authentic practice that is easily integrated into any new or existing curriculum. Reliable and affordable, Wallcur’s unique simulation and educational training supports evidence-based learning through hands-on practice. Practi-Products® include practice meds for unit dosages, reconstitution for IV’s, ampule and vial handling, injection techniques, and much more. State-of-the art instructional tutorials will help reduce instructor preparation time and provide a consistency for learning and debriefing. All Practi-Products® are not for human or animal use, they are designed realistic only for training purposes.

 

Join Wallcur and 3B Scientific on their joint journey to revolutionize healthcare education, one simulation at a time.

Click here to read the full press release.